IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 23 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAMDEN ASSET MANAGEMENT L P /CA | 36,225,000 | $40,606,000 | 1.41% |
Context Capital Management, LLC | 3,000,000 | $3,378,000 | 0.46% |
SHENKMAN CAPITAL MANAGEMENT INC | 3,808,000 | $4,308,000 | 0.45% |
AQR Arbitrage LLC | 7,500,000 | $8,444,000 | 0.30% |
Polar Asset Management Partners Inc. | 14,500,000 | $16,367,000 | 0.18% |
LINDEN ADVISORS LP | 9,300,000 | $10,496,000 | 0.08% |
Calamos Advisors LLC | 9,500,000 | $10,688,000 | 0.06% |
Jefferies Group LLC | 2,201,000 | $2,502,527 | 0.02% |
Citadel Advisors | 62,788,000 | $71,391,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 10,000,000 | $11,259,000 | 0.01% |